Results 51 to 60 of about 2,200,859 (305)

Efecto de la reducción de movilidad en la segunda ola de COVID-19. [PDF]

, 2021
Mientras en Uruguay estamos teniendo la primera ola de la pandemia Covid-19, en muchos países ya están sufriendo la segunda. Los riesgos de saturación del sistema sanitario llevan a muchos de estos países a tomar diferentes medidas, que incluyen desde el
Cabana, Álvaro, Etcheverry, Lorena, Fariello, María Inés, Fiori, Marcelo, Herrera, Daniel, Bermolen, Paola   +5 more
core   +2 more sources

Acceptability and feasibility of strategies to shield the vulnerable during the COVID-19 outbreak: a qualitative study in six Sudanese communities

BMC Public Health, 2021
Background Shielding of high-risk groups from coronavirus disease (COVID-19) has been suggested as a realistic alternative to severe movement restrictions during the COVID-19 epidemic in low-income countries. The intervention entails the establishment of
Nada Abdelmagid, Salma A. E. Ahmed, Nazik Nurelhuda, Israa Zainalabdeen, Aljaile Ahmed, Mahmoud Ali Fadlallah, Maysoon Dahab   +6 more
doaj   +1 more source

Serological Benefit of SARS‐CoV‐2 Vaccination Relative to Infection in Children With Acute Lymphoblastic Leukemia

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Children with acute lymphoblastic leukemia (ALL) are at risk of severe outcomes from SARS‐CoV‐2 (SCV2). In the post‐pandemic context, where most children have been infected with SCV2, there are limited data on whether vaccination remains beneficial in children with ALL.
Janna R. Shapiro, Freda Qi, Karen Colwill, Alina D. Dorogy, Ying Liu, Michelle Science, Anne‐Claude Gingras, James M. Rini, Sumit Gupta, Sarah Alexander, Shelly Bolotin, Tania H. Watts   +11 more
wiley   +1 more source

Clinical characteristics of patients with COVID-19 admitted to the COVID-19 Emergency Field Hospital of Bangkalan, Indonesia [version 2; peer review: 2 approved]

F1000Research, 2022
Background: Following the surge of coronavirus disease 2019 (COVID-19) cases in the epicenter of East Java Province, this study aimed to determine the clinical characteristics of patients with COVID-19 at one of the emergency field hospitals in Indonesia.
Ahmad Maulana Ifan Akbas, Nathania Djaja, Perthdyatama Syifaq Budiono, Kurnia Auliyana Ar-Rahmah, Erwin Astha Triyono, Fenska Seipalla, Yussika Fernanda, Aditya Putra Pamungkas, Clarissa Azalia Maheswari, Alfin Jam'Annuri   +9 more
doaj   +1 more source

Emapalumab for Immune Effector Cell‐Associated Hemophagocytic Lymphohistiocytosis‐Like Syndrome Following CD19‐Directed CAR‐T in Two Patients With B‐ALL: Clinical and Biomarker Correlates

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Immune effector cell‐associated hemophagocytic lymphohistiocytosis‐like syndrome (IEC‐HS) is a life‐threatening hyperinflammatory toxicity distinct from cytokine release syndrome (CRS) and neurotoxicity following chimeric antigen receptor T‐cell (CAR‐T) therapy. In a single‐institution retrospective cohort of pediatric and young adult patients
Thomas J. Galletta, Jeremy D. Rubinstein, Christopher E. Dandoy, Ruby Khoury, Angela Faulhaber, Christine L. Phillips, Christa Krupski   +6 more
wiley   +1 more source

Infection Control Practices for Vascular Access Management in Hemodialysis: Results From a Nationwide Survey of Japanese National University Hospitals

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction Bloodstream infections due to repeated vascular access (VA) puncture and circuit connections remain major concerns in hemodialysis. Therefore, we examined current practices for glove, disinfectant, and personal protective equipment (PPE) use according to VA type in national university hospitals in Japan.
Aiko Yamada, Makoto Harada, Tadahiko Kikugawa, Takeshi Nakata, Koji Hashimoto, Tsuneo Konta, Yuji Kamijo   +6 more
wiley   +1 more source

A Bibliometric Analysis of Publications in Uremic Toxins From 1991 to 2024

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Uremic toxins are a growing area of research in nephrology, with significant implications in the progression and treatment of chronic kidney disease (CKD) and the management of end‐stage kidney disease (ESKD). This bibliometric analysis aims to evaluate the global research trends, key contributors, and the impact of publications in ...
Yuh‐Shan Ho, Karim M. Soliman, Wisit Cheungpasitporn, Wannasit Wathanavasin, Ahmed Daoud, Ahmed I. Kamal, Balázs Szamosfalvi, Tibor Fülöp   +7 more
wiley   +1 more source

Emergence and expansion of highly infectious spike protein D614G mutant SARS-CoV-2 in central India

Scientific Reports, 2021
COVID-19 has emerged as global pandemic with largest damage to the public health, economy and human psyche.The genome sequence data obtained during the ongoing pandemic are valuable to understand the virus evolutionary patterns and spread across the ...
Shashi Sharma, Paban Kumar Dash, Sushil Kumar Sharma, Ambuj Srivastava, Jyoti S. Kumar, B. S. Karothia, K. T. Chelvam, Sandeep Singh, Abhaydeep Gupta, Ram Govind Yadav, Ruchi Yadav, T. S. Greeshma, Pramod Kumar Kushwaha, Ravi Bhushan Kumar, D. P. Nagar, Manvendra Nandan, Subodh Kumar, Duraipandian Thavaselvam, Devendra Kumar Dubey   +18 more
doaj   +1 more source

Characteristics and risk factors for post-COVID breathlessness after hospitalisation for COVID-19 [PDF]

, 2022
BACKGROUND: Persistence of respiratory symptoms—particularly breathlessness—after acute COVID-19 infection has emerged as a significant clinical problem.
Quint, Jennifer K., Jeremy S. Brown, PHOSP-COVID Study Collaborative Group, ., Evans, Rachael A., Bang Zheng, Zheng, Bang, Jenkins, Gisli, Luke S. Howard, Louise V. Wain, Amisha Singapuri, Pfeffer, Paul, Ho, Ling-Pei, Daines, Luke; id_orcid, Howard, Luke S., Sheikh, Aziz, Poinasamy, Krisnah, Horsley, Alex, Brightling, Christopher E, Chalmers, James D., Pfeffer, Paul E., Nazir I. Lone, Hamish McAuley, Docherty, Annemarie B., Lone, Nazir I., Liam G. Heaney, Docherty, Annemarie B, Marks, Michael, Wain, Louise V., Aarti Shikotra, Ling-Pei Ho, Omer Elneima, Samantha Walker, Gisli Jenkins, Anthony De Soyza, Siddiqui, Salman, ?, ?, Elneima, Omer, Jennifer K. Quint, Raman, Betty, Evans, Rachael A, Michael Marks, Heaney, Liam G, McAuley, Hamish, Brown, Jeremy S., Elizabeth Sapey, James D. Chalmers, Mark Toshner, Porter, Joanna C, Paul Pfeffer, Aziz Sheikh, Christopher E. Brightling, Brightling, Christopher E., Harrison, Ewen, Shikotra, Aarti, Marco Sereno, Annemarie B. Docherty, Sereno, Marco, Toshner, Mark, Salman Siddiqui, Brown, Jeremy S, Heaney, Liam G., Sapey, Elizabeth, Harrison, Ewen M; id_orcid, Betty Raman, Singapuri, Amisha, Hurst, John R., De Soyza, Anthony, Joanna C. Porter, Lone, Nazir I, John R. Hurst, Walker, Samantha, Alex Horsley, Hurst, John R, Chalmers, James D, Howard, Luke S, Wain, Louise V, Ewen Harrison, Luke Daines, Porter, Joanna C., Lone, Nazir I; id_orcid, Rachael A. Evans, Daines, Luke, Quint, Jennifer K, Krisnah Poinasamy   +83 more
core   +1 more source

Reciprocal control of viral infection and phosphoinositide dynamics

FEBS Letters, EarlyView.
Phosphoinositides, although scarce, regulate key cellular processes, including membrane dynamics and signaling. Viruses exploit these lipids to support their entry, replication, assembly, and egress. The central role of phosphoinositides in infection highlights phosphoinositide metabolism as a promising antiviral target.
Marie Déborah Bancilhon, Bruno Mesmin
wiley   +1 more source